The biopharmaceutical tubing market is projected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is expected to grow at a CAGR of 8.3% from 2021 to 2028.
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Tubing Market: Strategic Insights
Market Size Value in US$ 3,442.82 Million in 2021 Market Size Value by US$ 6,013.27 Million by 2028 Growth rate CAGR of 8.3% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biopharmaceutical Tubing Market: Strategic Insights
| Market Size Value in | US$ 3,442.82 Million in 2021 |
| Market Size Value by | US$ 6,013.27 Million by 2028 |
| Growth rate | CAGR of 8.3% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The biopharmaceutical tubing market is segmented on the bases of type, application, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.
Lucrative Regions for Biopharmaceutical Tubing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Elderly Population Drives Biopharmaceutical Tubing Market Growth
Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age more than 60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people of age more than 60, i.e., 25%. By 2050, ~25% or more population in all regions of the world, except Africa, would be of age 60 and above. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.
This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the surge in the incidence of chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.
Rising Demand for Minimally Invasive Procedures Contributes Significantly to Market Growth
A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain.
The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Furthermore, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.
Type Insights
Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021–2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing. In addition to biocompatibility, high temperature and chemical resistance, mechanical strength, and electric properties are among the properties that make it a material of choice in biological applications.
Application Insights
Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment is sub segmented as single use technology and others. The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.
Biopharmaceutical Tubing Market, by Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product launches, and mergers and acquisitions are the highly adopted strategies by the players operating in the global biopharmaceutical tubing market. A few of the recent key product developments are listed below:
In September 2021, DuPont introduced DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The Liveo brand product line includes pharmaceutical tubing and overmolded assemblies for single-use systems in biopharma processing, transdermal and topical drug delivery systems, and medical adhesives, among others.
In June 2020, Nordson acquired Fluortek, a plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. As Nordson Medical continues to expand its diversified product offerings, the acquisition enhances company's ability to deliver critical components for medical device innovations.
The COVID-19 pandemic is having the mixed impact on the biopharmaceutical tubing market. Growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes also influences the growth of the market. There is a rise in the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, spacer devices, etc. Therefore, these factors are driving the demand for biopharmaceutical tubing during the forecast period. On the other hand, many countries have changed medical device regulations owing to supply chain obstruction affect negatively on biopharmaceutical tubing market.
Biopharmaceutical Tubing – Market Segmentation
By Type
- Silicone
- Plastic
- Metal
By Application
- Pharmaceutical
- Single Use Technology
- Others
- Medical Devices
- Research and Development
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc.
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
- Specialty Silicone Products, Inc.
- Hoshine Silicon Industry Co., Ltd.
- Wacker Chemie AG
- Shin-Etsu Chemical Co., Ltd.
- Momentive
- Elkem ASA
- Wacker Chemie AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The factors such as increasing elderly population in world and rising demand for minimally invasive procedures drive the market growth. However, the stringent regulatory framework hinders the market growth.
The biopharmaceutical tubing market majorly consists of the players such W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG among others.
Biopharmaceutical tubing is specifically designed to meet critical needs of biopharmaceutical and medical industries. Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.
Use of platinum-cured silicone as material of choice for biopharmaceutical tubing is likely to act as a trend the market growth in the coming years.
Silicone segment is growing in the biopharmaceutical tubing market.
Proliferation of healthcare sector and rise in prevalence of chronic diseases in developing countries is likely to fuel the market growth in the coming years.
Asia-Pacific is lucrative for the biopharmaceutical tubing market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biopharmaceutical Tubing Market – By Type
1.3.2 Global Biopharmaceutical Tubing Market – By Application
1.3.3 Global Biopharmaceutical Tubing market – By Geography
2. Biopharmaceutical Tubing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Biopharmaceutical Tubing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.3 Middle East and Africa (MEA) – PEST Analysis
4.3.1 South and Central America (SCAM) – PEST Analysis
4.4 Expert Opinions
5. Investment in Biopharmaceutical Tubing
5.1 Introduction
5.2 Investment Made by Companies
6. Price of Overall Silicone Feedstock in Regions - Biopharmaceutical Tubing Market
6.1 North America
6.2 Europe
6.3 Asia Pacific
7. Adoption of Alternative Materials
8. Supply Shortages Faced by the Market Participants - Biopharmaceutical Tubing Market
8.1 Causes
9. Price Fluctuation
10. Total Production Capacity of Major Player -Biopharmaceutical Tubing Market
11. Biopharmaceutical Tubing Market – Key Market Dynamics
11.1 Drivers
11.1.1 Increasing Elderly Population in World
11.1.2 Rising Demand for Minimally Invasive Procedures
11.2 Market Restraints
11.2.1 Stringent Regulatory Framework
11.3 Market Opportunities
11.3.1 Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries
11.4 Future Trends
11.4.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing
11.5 Impact Analysis
12. Biopharmaceutical Tubing Market – Global Analysis
12.1 Global Biopharmaceutical Tubing Market Revenue Forecast And Analysis
12.2 Global Biopharmaceutical Tubing Market, By Geography - Forecast And Analysis
12.3 Market Positioning of Key Players
13. Biopharmaceutical Tubing Market – Volume Analysis
13.1.1 Global: Biopharmaceutical Tubing Market, by Volume, 2019–2028 (Million Units)
14. Biopharmaceutical Tubing Market Analysis – By Type
14.1 Overview
14.2 Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
14.3 Plastic
14.3.1 Overview
14.3.2 Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
14.4 Metal
14.4.1 Overview
14.4.2 Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
14.5 Silicone
14.5.1 Overview
14.5.2 Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
15. Biopharmaceutical Tubing Market Analysis – By Application
15.1 Overview
15.2 Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
15.3 Pharmaceutical
15.3.1 Overview
15.3.2 Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
15.4 Medical Devices
15.4.1 Overview
15.4.2 Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
15.5 Research and Development
15.5.1 Overview
15.5.2 Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
15.6 Others
15.6.1 Overview
15.6.2 Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
16. Biopharmaceutical Tubing Market – Geographic Analysis
16.1 North America: Biopharmaceutical Tubing Market
16.1.1 Overview
16.1.2 North America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.3 North America: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.1.4 North America: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.1.4.1 North America: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.1.5 North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.1.5.1 US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.1.1 US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.1.2 US: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.1.5.1.3 US: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.1.5.1.3.1 US: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.1.5.2 Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.2.1 Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.2.2 Canada: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.1.5.2.3 Canada: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.1.5.2.3.1 Canada: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.1.5.3 Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.3.1 Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.1.5.3.2 Mexico Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.1.5.3.3 Mexico Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
16.1.5.3.3.1 Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.2 Europe: Biopharmaceutical Tubing Market
16.2.1 Overview
16.2.2 Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.3 Europe: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.4 Europe: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.4.1 Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5 Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028(%)
16.2.5.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.1.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.1.2 Germany: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.1.3 Germany: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.1.3.1 Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5.2 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.2.1 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.2.2 France: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.2.3 France: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.2.3.1 France: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5.3 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.3.1 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.3.2 UK: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.3.3 UK: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.3.3.1 UK: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5.4 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.4.1 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.4.2 Italy: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.4.3 Italy: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.4.3.1 Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5.5 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.5.1 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.5.2 Spain: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.5.3 Spain: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.5.3.1 Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.2.5.6 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.6.1 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.2.5.6.2 Rest of Europe: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.2.5.6.3 Rest of Europe: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.2.5.6.3.1 Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3 Asia Pacific: Biopharmaceutical Tubing Market
16.3.1 Overview
16.3.2 Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.3 Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.4 Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.4.1 Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5 Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.3.5.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.1.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.1.2 Japan: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.1.3 Japan: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.1.3.1 Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5.2 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.2.1 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.2.2 China: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.2.3 China: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.2.3.1 China: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5.3 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.3.1 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.3.2 India: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.3.3 India: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.3.3.1 India: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5.4 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.4.1 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.4.2 South Korea: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.4.3 South Korea: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.4.3.1 South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5.5 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.5.1 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.5.2 Australia: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.5.3 Australia: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.5.3.1 Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.3.5.6 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.6.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.3.5.6.2 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
16.3.5.6.3 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
16.3.5.6.3.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)
16.4 Middle East & Africa: Biopharmaceutical Tubing Market
16.4.1 Overview
16.4.2 Middle East & Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
16.4.3 Middle East & Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.4.4 Middle East & Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
16.4.4.1 Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.4.5 Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.4.5.1 Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.1.1 Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.1.2 Saudi Arabia Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.4.5.1.3 Saudi Arabia Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
16.4.5.1.3.1 Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.4.5.2 UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.2.1 UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.2.2 UAE Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.4.5.2.3 UAE Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
16.4.5.2.3.1 UAE Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.4.5.3 South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.3.1 South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.3.2 South Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.4.5.3.3 South Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
16.4.5.3.3.1 South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.4.5.4 Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.4.1 Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.4.5.4.2 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.4.5.4.3 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
16.4.5.4.3.1 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.5 South and Central America: Biopharmaceutical Tubing Market
16.5.1 Overview
16.5.2 South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.3 South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.5.4 South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
16.5.4.1 South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.5.5 South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.5.5.1 Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.1.1 Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.1.2 Brazil Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.5.5.1.3 Brazil Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
16.5.5.1.3.1 Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.5.5.2 Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.2.1 Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.2.2 Argentina Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.5.5.2.3 Argentina Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
16.5.5.2.3.1 Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
16.5.5.3 Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.3.1 Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
16.5.5.3.2 Rest of South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
16.5.5.3.3 Rest of South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
16.5.5.3.3.1 Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
17. Impact of COVID-19 Pandemic on Global Biopharmaceutical Tubing Market
17.1 Global Impact of COVID-19
17.2 North America: Impact Assessment of COVID-19 Pandemic
17.3 Europe: Impact Assessment of COVID-19 Pandemic
17.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
17.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
17.6 South and Central America: Impact Assessment of COVID-19 Pandemic
18. Biopharmaceutical Tubing Market – Industry Landscape
18.1 Overview
18.2 Growth Strategies Done by the Companies in the Market, (%)
18.3 Organic Developments
18.3.1 Overview
18.4 Inorganic Developments
18.4.1 Overview
19. Company Profiles
19.1 W. L. Gore and Associates, Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Products and Services
19.1.4 Financial Overview
19.1.5 SWOT Analysis
19.1.6 Key Developments
19.2 Saint-Gobain Sekurit
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Products and Services
19.2.4 Financial Overview
19.2.5 SWOT Analysis
19.2.6 Key Developments
19.3 Freudenberg Group
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Products and Services
19.3.4 Financial Overview
19.3.5 SWOT Analysis
19.3.6 Key Developments
19.4 RAUMEDIC AG
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Products and Services
19.4.4 Financial Overview
19.4.5 SWOT Analysis
19.4.6 Key Developments
19.5 TEKNI-PLEX
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Products and Services
19.5.4 Financial Overview
19.5.5 SWOT Analysis
19.5.6 Key Developments
19.6 NewAge Industries, Inc.
19.6.1 Key Facts
19.6.2 Business Description
19.6.3 Products and Services
19.6.4 Financial Overview
19.6.5 SWOT Analysis
19.6.6 Key Developments
19.7 Optinova
19.7.1 Key Facts
19.7.2 Business Description
19.7.3 Products and Services
19.7.4 Financial Overview
19.7.5 SWOT Analysis
19.7.6 Key Developments
19.8 Zeus Industrial Products, Inc.
19.8.1 Key Facts
19.8.2 Business Description
19.8.3 Products and Services
19.8.4 Financial Overview
19.8.5 SWOT Analysis
19.8.6 Key Developments
19.9 NORDSON CORPORATION
19.9.1 Key Facts
19.9.2 Business Description
19.9.3 Products and Services
19.9.4 Financial Overview
19.9.5 SWOT Analysis
19.9.6 Key Developments
19.10 DuPont de Nemours, Inc.
19.10.1 Key Facts
19.10.2 Business Description
19.10.3 Products and Services
19.10.4 Financial Overview
19.10.5 SWOT Analysis
19.10.6 Key Developments
20. Company Profiles – For Supplier
20.1 Specialty Silicone Products, Inc.
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Products and Services
20.1.4 Financial Overview
20.2 Hoshine Silicon Industry Co., Ltd.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Products and Services
20.2.4 Financial Overview
20.3 Wacker Chemie AG
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Products and Services
20.3.4 Financial Overview
20.4 Shin-Etsu Chemical Co., Ltd.
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Products and Services
20.4.4 Financial Overview
20.5 Momentive
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Products and Services
20.5.4 Financial Overview
20.6 Elkem ASA
20.6.1 Key Facts
20.6.2 Business Description
20.6.3 Products and Services
20.6.4 Financial Overview
20.7 Avantor, Inc.
20.7.1 Key Facts
20.7.2 Business Description
20.7.3 Products and Services
20.7.4 Financial Overview
21. Appendix
21.1 About The Insight Partners
21.2 Glossary of Terms
LIST OF TABLES
Table 1. Adoption of Alternative Materials
Table 2. Global Biopharmaceutical Tubing Market, by Volume – Volume and Forecast to 2028 (Million Units)
Table 3. North America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 6. US Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 7. US Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. US Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Europe: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Germany: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 21. France: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 22. France: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 23. France: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 26. UK: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Italy: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 29. Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 31. Spain: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 32. Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 37. Asia Pacific: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 38. Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 39. Japan: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 40. Japan: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 41. Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 42. China: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 43. China: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 44. China: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 45. India: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 46. India: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 47. India: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 49. South Korea: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 50. South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 51. Australia: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 52. Australia: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 53. Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East & Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 58. Middle East & Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 59. Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 61. Saudi Arabia Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 62. Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 63. UAE Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 64. UAE Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 65. UAE Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 66. South Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 67. South Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 73. South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 76. Brazil Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 79. Argentina Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 80. Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. Rest of South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 83. Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)
Table 84. Organic Developments Done By Companies
Table 85. Inorganic Developments Done By Companies
Table 86. Glossary of Terms, Biopharmaceutical Tubing Market
LIST OF FIGURES
Figure 1. Biopharmaceutical Tubing Market Segmentation
Figure 2. Biopharmaceutical Tubing Market Segmentation, By Region
Figure 3. Biopharmaceutical Tubing Market Overview
Figure 4. Silicone Segment Held Largest Share of Biopharmaceutical Tubing Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Biopharmaceutical Tubing Market, by Geography (US$ Million)
Figure 7. Global Biopharmaceutical Tubing Market – Leading Country Markets (US$ Million)
Figure 8. Global Biopharmaceutical Tubing Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Price Fluctuation By Region
Figure 15. Total Production Capacity of Major Players
Figure 16. Global Biopharmaceutical Tubing Market – Revenue Forecast And Analysis – 2020- 2028
Figure 17. Global Biopharmaceutical Tubing Market – By Geography Forecast and Analysis – 2020- 2028
Figure 18. Market Positioning of Key Players In Global Biopharmaceutical Tubing Market
Figure 19. Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
Figure 20. Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
Figure 24. Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 30. North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 31. US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Europe: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 35. Europe: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 37. Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Asia Pacific: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. Asia Pacific: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 46. Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Middle East & Africa: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 53. Middle East & Africa Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 55. Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South and Central America: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 60. South and Central America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 61. South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 62. Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in North American Countries
Figure 66. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in European Countries
Figure 67. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 68. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in Middle East and Africa
Figure 69. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in South and Central America
Figure 70. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Biopharmaceutical Tubing Market
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc.
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
- Specialty Silicone Products, Inc.
- Hoshine Silicon Industry Co., Ltd.
- Wacker Chemie AG
- Shin-Etsu Chemical Co., Ltd.
- Momentive
- Elkem ASA
- Wacker Chemie AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Biopharmaceutical Tubing Market
Feb 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)